| dbo:abstract |
Genta Incorporated was a biopharmaceutical company started in La Jolla, California, which discovered and developed innovative drugs for the treatment of patients with cancer. Founded in 1989 by a highly skilled entrepreneur, the company focused on a novel technology known as antisense, which targets gene products that are associated with the onset and progression of serious diseases. At that time, only Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) (formerly Isis Pharmaceuticals until December 2015) was conducting significant research with this technology. Antisense is a short span of oligonucleotides – modified DNA structures ranging from about 12-24 bases that selectively bind to specific RNA. The intent is to block expression of an aberrant protein that contributes to the disease of interest. Genta in-licensed three different antisense molecules that blocked Bcl-2, a fibroblast growth factor (FGF), and the gene c-myb, respectively. (en) |
| dbo:industry |
dbr:Biotechnology |
| dbo:location |
dbr:Berkeley_Heights,_New_Jersey |
| dbo:product |
dbr:Ganite dbr:Tesetaxel dbr:Genasense |
| dbo:thumbnail |
wiki-commons:Special:FilePath/Genta-logo.png?width=300 |
| dbo:wikiPageExternalLink |
http://www.genta.com https://web.archive.org/web/20100305211758/http:/www.genta.com:80/ |
| dbo:wikiPageID |
25747931 (xsd:integer) |
| dbo:wikiPageLength |
28505 (xsd:nonNegativeInteger) |
| dbo:wikiPageRevisionID |
1095740038 (xsd:integer) |
| dbo:wikiPageWikiLink |
dbr:Bcl-2 dbr:Berkeley_Heights,_New_Jersey dbr:Antisense_RNA dbr:Cystic_fibrosis dbr:Venetoclax dbc:Biotechnology_companies_established_in_1989 dbc:Biotechnology_companies_of_the_United_States dbr:Melanoma dbc:Pharmaceutical_companies_established_in_1989 dbr:Oligonucleotide dbr:Parathyroid_carcinoma dbr:Pseudomonas_aeruginosa dbr:Chronic_lymphocytic_leukemia dbr:Genentech dbr:Apoptosis dbr:Lexington,_MA dbr:Calcitonin dbr:Short_Hills,_NJ dbr:Ganite dbc:Companies_that_filed_for_Chapter_11_bankruptcy_in_2012 dbc:Pharmaceutical_companies_based_in_New_Jersey dbr:File:Genta-logo.png dbr:AbbVie dbc:1989_establishments_in_California dbr:Dacarbazine dbr:Daiichi_Sankyo dbr:FDA dbr:Paclitaxel dbr:Paget's_disease_of_bone dbc:Companies_based_in_Union_County,_New_Jersey dbr:Ionis_Pharmaceuticals dbr:Taxane dbr:Taxol dbr:Temozolomide dbr:Tesetaxel dbr:Chemotherapy dbr:La_Jolla dbr:Biopharmaceutical dbr:Biotechnology dbr:Docetaxel dbr:Bone_resorption dbr:Fibroblast dbr:Antisense dbr:Schering_Plough dbr:New_York_City dbr:Genasense dbr:La_Jolla,_California dbr:Taxotere dbr:Venclexta dbr:Temodar dbr:P-glycoprotein dbr:Serum_calcium dbr:Taxanes dbr:Hypercalcemia dbr:Myeloma dbr:Etidronate dbr:Memorial_Sloan-Kettering dbr:U.S._National_Cancer_Institute |
| dbp:homepage |
http://www.genta.com |
| dbp:industry |
dbr:Biotechnology |
| dbp:location |
dbr:Berkeley_Heights,_New_Jersey |
| dbp:logo |
220 (xsd:integer) |
| dbp:name |
Genta, Inc. (en) |
| dbp:products |
dbr:Ganite dbr:Tesetaxel dbr:Genasense |
| dbp:wikiPageUsesTemplate |
dbt:Citation_needed dbt:Coord dbt:Infobox_company dbt:Reflist dbt:Pharmaceutical_companies_of_the_United_States |
| dcterms:subject |
dbc:Biotechnology_companies_established_in_1989 dbc:Biotechnology_companies_of_the_United_States dbc:Pharmaceutical_companies_established_in_1989 dbc:Companies_that_filed_for_Chapter_11_bankruptcy_in_2012 dbc:Pharmaceutical_companies_based_in_New_Jersey dbc:1989_establishments_in_California dbc:Companies_based_in_Union_County,_New_Jersey |
| georss:point |
40.6638 -74.4148 |
| rdf:type |
owl:Thing dbo:Company schema:Organization dul:Agent dul:SocialPerson dbo:Agent wikidata:Q24229398 wikidata:Q43229 wikidata:Q4830453 yago:WikicatBiotechnologyCompaniesOfTheUnitedStates yago:WikicatCompaniesBasedInUnionCounty,NewJersey yago:WikicatCompaniesListedOnTheOTCBulletinBoard geo:SpatialThing yago:Abstraction100002137 yago:Company108058098 yago:DrugCompany108002578 yago:Group100031264 yago:Institution108053576 yago:Organization108008335 yago:YagoLegalActor yago:YagoLegalActorGeo yago:YagoPermanentlyLocatedEntity dbo:Organisation yago:SocialGroup107950920 yago:WikicatPharmaceuticalCompaniesBasedInNewJersey |
| rdfs:comment |
Genta Incorporated was a biopharmaceutical company started in La Jolla, California, which discovered and developed innovative drugs for the treatment of patients with cancer. Founded in 1989 by a highly skilled entrepreneur, the company focused on a novel technology known as antisense, which targets gene products that are associated with the onset and progression of serious diseases. At that time, only Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) (formerly Isis Pharmaceuticals until December 2015) was conducting significant research with this technology. Antisense is a short span of oligonucleotides – modified DNA structures ranging from about 12-24 bases that selectively bind to specific RNA. The intent is to block expression of an aberrant protein that contributes to the disease of interes (en) |
| rdfs:label |
Genta (company) (en) |
| owl:sameAs |
freebase:Genta (company) yago-res:Genta (company) wikidata:Genta (company) https://global.dbpedia.org/id/4kJ4G |
| geo:geometry |
POINT(-74.41480255127 40.663799285889) |
| geo:lat |
40.663799 (xsd:float) |
| geo:long |
-74.414803 (xsd:float) |
| prov:wasDerivedFrom |
wikipedia-en:Genta_(company)?oldid=1095740038&ns=0 |
| foaf:depiction |
wiki-commons:Special:FilePath/Genta-logo.png |
| foaf:homepage |
http://www.genta.com |
| foaf:isPrimaryTopicOf |
wikipedia-en:Genta_(company) |
| foaf:name |
Genta, Inc. (en) |
| is dbo:wikiPageDisambiguates of |
dbr:Genta |
| is dbo:wikiPageRedirects of |
dbr:Genta_(Company) dbr:Genta_Incorporated |
| is dbo:wikiPageWikiLink of |
dbr:Bcl-2 dbr:Betsy_McCaughey dbr:List_of_pharmaceutical_compound_number_prefixes dbr:Genta dbr:Ionis_Pharmaceuticals dbr:Oblimersen dbr:Genta_(Company) dbr:Genta_Incorporated |
| is foaf:primaryTopic of |
wikipedia-en:Genta_(company) |
